Sharing Life Sciences Innovations
Acquisitions of Biotech companies: a good or a bad thing?
When on the 8th January 2018 the news travelled that Novo Nordisk made a €2.6bn bid for Belgium’s Ablynx, only to be leapfrogged a few weeks later by the € 3.9bn Sanofi bid, we immediately picture…
Cycling for Science
Researchers from Ghent University have been able to map the effects of climate change thanks to images of the Tour of Flanders. By studying 36 years of footage of the popular cycling race, the res…
1 billion lifeforms recorded!
The Global Biodiversity Information Facility (GBIF) is an international network that provides access to a huge biodiversity database. Their total number of occurrence records just reached 1 billio…
Damya Laoui at the forefront of cancer immunotherapy
Photo copyright: VUB / Thierry Geenen Last year, Damya Laoui received the prestigious American MIT-prize for young innovators under 35 for her research on cancer immunotherapy. She is current…
Increase feeding success with VIPUN Medical’s new technology
Critically ill patients are often fed through nasogastric tubes. It is however hard for physicians to know if the stomach of these patients is working properly, which is important to know, as over…
DNA as a storage device for big data
Sometimes science fiction seems to become real right in front of our eyes. Slowly but surely, our genes are revealing all their secrets to us. We are currently able to read our genetic code faster…
Curing hay fever - ASIT Biotech allergy vaccines
The sun is shining, the grass is green, but hay fever season is at its peak! Many people (myself included) will spend a lot of money on antihistamines and tissues this summer. Wouldn’t it be lovel…
How to build a “European Amgen”
There are still very few large European biotech companies to compete with the Amgens and Gileads of the world. Only a handful of European biotech companies have managed to stay independent, grow,…
Is innovation killing the pharmaceutical industry?
In the past few years, the speed at which new drugs have been coming to the market has accelerated significantly [1]. This means there is a lot more competition than before, greatly affecting the …
Confo Therapeutics is awarded a EUR 1M grant to increase its screening capabilities
Confo Therapeutics announced today that it has received a €1 million grant from the Flemish Government through Flanders Innovation & Entrepreneurship (VLAIO). The grant will be used to support the…
Sanofi acquires Ablynx for €3.9 billion
Sanofi and Ablynx entered into a definitive agreement under which Sanofi will offer to acquire all of the outstanding ordinary shares, including shares represented by American Depositary Shares (A…
Nominations open for Dr. Paul Janssen Award
Have you ever heard from the Dr. Paul Janssen award? It's an acknowledgement for biomedical research almost as important as a Nobel Prize. A trophy sculpture, along with $200,000 cash, will go to …
Join our 20.000 subscribers and receive the monthly newsletter for free!
Upcoming events
Dr. Paul Janssen Award for Biomedical Research
Janssen Pharmaceutica, Turnhoutseweg 30, 2340 Beerse
Thu 06 Sep 2018
16:30
Johnson & Johnson has named James Allison, Ph.D., of University of Texas MD Anderson Cancer Center, winner of the 2018 Dr. Paul Janssen Award for Biomedical Research. Dr. Allison won for pioneerin…
Structural Dynamics in Cellular Communication (2nd edition)
Brussels, Belgium
Thu 20 Sep 2018 - Fri 21 Sep 2018
20 Sep 09:00
- 21 Sep 17:00
After a successful first edition in January 2015, with a great audience and speakers such as Nobel Prize winner Ada Yonath, we are honored to announce a second edition. This conference wi…
Business Developers Program for Life Sciences - Course
Amsterdam, The Netherlands
Tue 25 Sep 2018 - Wed 26 Sep 2018
25 Sep 08:30
- 26 Sep 17:30
On 25 & 26 September 2018 the Business Developers Program (BDP) Course will take place at the EY office in Amsterdam. This BDP Course specifically aims at junior to mid-level BD professionals who …
